Researchers at the University of Michigan, MoreBetter (Releaf app), EVEN and Overcome announced that they are recruiting California residents to participate in a 12-week study focused on the effectiveness of various cannabinoid capsules and tablets for treating chronic pain “associated with fibromyalgia, rheumatoid arthritis, osteoarthritis and overall quality of life.” .
Researchers aim to fill the significant gaps in cannabinoid research regarding efficacy in specific types of chronic pain, different product formulations, and dosages. According to a press release “Normalizing Product Type on Tablets and Capsules,” this study is the first “to examine trends in efficacy related to dosing in combination with unique product formulations.”
This study is also designed to help patients and physicians better understand how cannabinoid medicine can be used as a natural and effective therapy, as more than 40 million people are living with these conditions and even more are struggling with chronic pain.
Appealing to medical cannabis users in California
Eligible California Residents Those interested can take part in this study from home with their smartphone and answer standardized questionnaires on pain and quality of life.
“Enrolled participants will receive a 12-week supply of LEVEL and Overcome study products,” according to a press release. Besides the Study supply partner, FLOWER COA delivery company licensed in California will be responsible for shipping the study products to participants.
Participants who complete the study can receive up to $500 in Amazon AMZN gift cards. Register at releaf.at/umpain.
Researchers agree
Daniel Krueger, Ph.D.said the study’s lead investigator: “Pain is one of the most common diseases in humans use medicinal cannabis to treat, adding that the US National Academies of Sciences, Engineering and Medicine concluded that cannabis is effective in relieving pain.
According to Kruger, this conclusion is “only the…
